These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24667162)

  • 1. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential.
    Klinkhammer BM; Kramann R; Mallau M; Makowska A; van Roeyen CR; Rong S; Buecher EB; Boor P; Kovacova K; Zok S; Denecke B; Stuettgen E; Otten S; Floege J; Kunter U
    PLoS One; 2014; 9(3):e92115. PubMed ID: 24667162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
    Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
    Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells.
    Kim H; Yu MR; Lee H; Kwon SH; Jeon JS; Han DC; Noh H
    Aging Cell; 2021 Feb; 20(2):e13317. PubMed ID: 33524231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.
    van Koppen A; Joles JA; van Balkom BW; Lim SK; de Kleijn D; Giles RH; Verhaar MC
    PLoS One; 2012; 7(6):e38746. PubMed ID: 22723882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.
    da Silva AF; Silva K; Reis LA; Teixeira VP; Schor N
    Cell Transplant; 2015; 24(12):2657-66. PubMed ID: 25695732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of multipotency and molecular profile of MSCs between CKD and healthy rats.
    Yamada A; Yokoo T; Yokote S; Yamanaka S; Izuhara L; Katsuoka Y; Shimada Y; Shukuya A; Okano HJ; Ohashi T; Ida H
    Hum Cell; 2014 Apr; 27(2):59-67. PubMed ID: 24496821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins.
    Yoon YM; Lee JH; Song KH; Noh H; Lee SH
    J Pineal Res; 2020 Apr; 68(3):e12632. PubMed ID: 31989677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP
    Han YS; Kim SM; Lee JH; Jung SK; Noh H; Lee SH
    J Pineal Res; 2019 Jan; 66(1):e12535. PubMed ID: 30372554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney Disease.
    van Rhijn-Brouwer FCC; van Balkom BWM; Papazova DA; Hazenbrink DHM; Meijer AJ; Brete I; Briceno V; van Zuilen AD; Toorop RJ; Fledderus JO; Gremmels H; Verhaar MC
    Stem Cells Int; 2019; 2019():1232810. PubMed ID: 31933648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
    Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
    Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosis.
    Isik B; Thaler R; Goksu BB; Conley SM; Al-Khafaji H; Mohan A; Afarideh M; Abumoawad AM; Zhu XY; Krier JD; Saadiq IM; Tang H; Eirin A; Hickson LJ; van Wijnen AJ; Textor SC; Lerman LO; Herrmann SM
    Stem Cell Res Ther; 2021 Apr; 12(1):240. PubMed ID: 33853680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease.
    Sohi GK; Farooqui N; Mohan A; Rajagopalan KS; Xing L; Zhu XY; Jordan K; Krier JD; Saadiq IM; Tang H; Hickson LJ; Eirin A; Lerman LO; Herrmann SM
    Stem Cell Res Ther; 2024 Jun; 15(1):162. PubMed ID: 38853239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease.
    Wang Y; Guo YF; Fu GP; Guan C; Zhang X; Yang DG; Shi YC
    Stem Cell Res Ther; 2020 Jul; 11(1):274. PubMed ID: 32641100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects.
    Osugi M; Katagiri W; Yoshimi R; Inukai T; Hibi H; Ueda M
    Tissue Eng Part A; 2012 Jul; 18(13-14):1479-89. PubMed ID: 22443121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
    Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
    Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived mesenchymal stem cells transplantation ameliorates renal injury through anti-fibrotic and anti-inflammatory effects in chronic experimental renovascular disease.
    Almeida A; Lira R; Oliveira M; Martins M; Azevedo Y; Silva KR; Carvalho S; Cortez E; Stumbo AC; Carvalho L; Thole A
    Biomed J; 2022 Aug; 45(4):629-641. PubMed ID: 34333108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoidan Rescues p-Cresol-Induced Cellular Senescence in Mesenchymal Stem Cells via FAK-Akt-TWIST Axis.
    Lee JH; Yun CW; Hur J; Lee SH
    Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29642406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.
    Qi S; Wu D
    Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.